Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by β1 integrins
Short, Sarah M.
Narsimhan, Radha P.
Ingber, Donald E.
Zetter, Bruce R.
MetadataShow full item record
CitationShort, Sarah M., Alexandrine Derrien, Radha P. Narsimhan, Jack Lawler, Donald E. Ingber, and Bruce R. Zetter. 2005. “Inhibition of Endothelial Cell Migration by Thrombospondin-1 Type-1 Repeats Is Mediated by β1integrins.” The Journal of Cell Biology 168 (4): 643–53. https://doi.org/10.1083/jcb.200407060.
AbstractThe anti-angiogenic effect of thrombospondin-1 has been shown to be mediated through binding of the type-1 repeat (TSR) domain to the CD36 transmembrane receptor. We now report that the TSR domain can inhibit VEGF-induced migration in human umbilical vein endothelial cells (HUVEC), cells that lack CD36. Moreover, we identified beta(1) integrins as a critical receptor in TSR-mediated inhibition of migration in HUVEC. Using pharmacological inhibitors of downstream VEGF receptor effectors, we found that phosphoinositide 3-kinase (PI3k) was essential for TSR-mediated inhibition of HUVEC migration, but that neither PLCgamma nor Akt was necessary for this response. Furthermore, beta1 integrins were critical for TSR-mediated inhibition of microvascular endothelial cells, cells that express CD36. Together, our results indicate that P, integrins mediate the anti-migratory effects of TSR through a PI3k-dependent mechanism.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:41467425
- FAS Scholarly Articles